These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
664 related items for PubMed ID: 19520878
1. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes. Crasto W, Jarvis J, Khunti K, Davies MJ. Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878 [Abstract] [Full Text] [Related]
2. Why, when and how to initiate insulin therapy in patients with type 2 diabetes. Tibaldi J, Rakel RE. Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436 [Abstract] [Full Text] [Related]
3. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes. Baxter MA. Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296 [Abstract] [Full Text] [Related]
4. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW. Clin Ther; 2007 Dec; 29 Suppl D():S135-44. PubMed ID: 18191065 [Abstract] [Full Text] [Related]
6. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study. Hermansen K, Dornhorst A, Sreenan S. Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940 [Abstract] [Full Text] [Related]
7. Premixed insulin treatment for type 2 diabetes: analogue or human? Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056 [Abstract] [Full Text] [Related]
8. How well do rapid-acting insulins work in obese individuals? Barnett AH. Diabetes Obes Metab; 2006 Jul; 8(4):388-95. PubMed ID: 16776745 [Abstract] [Full Text] [Related]
9. Perspectives in type 2 diabetes: incorporating the latest insulin analogue strategies to achieve treatment success. Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():iii-iv. PubMed ID: 19817775 [Abstract] [Full Text] [Related]
10. Oral insulin - a review of current status. Iyer H, Khedkar A, Verma M. Diabetes Obes Metab; 2010 Mar; 12(3):179-85. PubMed ID: 20151994 [Abstract] [Full Text] [Related]
11. Primary care diabetes. What options are there? Yeap BB. Aust Fam Physician; 2001 Dec; 30(12):1122-8. PubMed ID: 11838389 [Abstract] [Full Text] [Related]
13. Insulin therapy in type 2 diabetes for physicians and practitioners. Das AK. J Indian Med Assoc; 2008 Nov; 106(11):741-2, 744-6. PubMed ID: 19368100 [Abstract] [Full Text] [Related]
14. Which insulin, regimen and device in type 2 diabetes? Drug Ther Bull; 2010 Dec; 48(12):134-8. PubMed ID: 21123289 [Abstract] [Full Text] [Related]
15. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel. Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116 [Abstract] [Full Text] [Related]
16. Guidelines for insulin management of diabetes in school. Silverstein J, Patrick S. School Nurse News; 2007 Mar; 24(2):9-12. PubMed ID: 17393819 [No Abstract] [Full Text] [Related]
17. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient. Meneghini L. Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822 [Abstract] [Full Text] [Related]